The biopharma’s layoff woes continue to make headlines, but the news is not all negative. To get a clearer picture, we gathered data on layoffs, new plant announcements and companies hiring, including specific coordinates for locations down to the address level, when possible. After clustering the data, we identified the top- and worst-performing global hubs.…
Biotech market projection for 2024 could point to more sector stability
The biotech sector could see a period of relative stability, according to a time-series analysis of the NASDAQ Biotech Index. In recent years, however, performance of the NBI has had little bearing on the rate of layoffs in the pharma and biotech sectors. A statistical analysis of the relationship between the NBI performance and the…
10 major pharma and biotech companies that downsized in 2023
The biopharma industry faced mounting headwinds in 2023, with several major players announcing significant restructuring efforts. Faced with expiring patents, inflation and rising interest rates, and heightened FTC scrutiny, companies looked to trim expenses and refocus their businesses. The ebbing tied of the pandemic posed a challenge for a number of drug developers as well.…